AKBA vs CMS · rev $160.2M vs P/E 20, $22.42B cap
Akebia Ther (AKBA) versus CMS Energy Corporation (CMS) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Latest reported AKBA revenue for 2024-12-31 was $160.2M. Net income was -$69.4M. Revenue was down 17.7% from 2023-12-31 to 2024-12-31. AKBA currently screens at market cap $260.1M.
CMS does not have a complete income-statement cache yet.
AKBA currently screens at market cap $260.1M. CMS currently screens at market cap $22.42B and trailing P/E 20.1.
Not investment advice. Open the AKBA and CMS stock pages for the full models.
Not investment advice.